by Truveta staff | Mar 29, 2024 | Research
Prior to the new Medicare guidelines going into effect, Truveta Research and Zeke Emanuel, MD, PhD from the University of Pennsylvania, explored the first-time prescribing and dispensing of anti-obesity GLP-1 RA medications for US adults aged 60 to 69 with obesity or...
by Truveta staff | Mar 12, 2024 | Data
Stories from women whose endometriosis pain has been dismissed are devastatingly common. A typical woman in the United States will wait 10 years after her symptoms first appear to receive an endometriosis diagnosis. This delay is rooted in a pervasive lack of...
by Truveta staff | Mar 11, 2024 | Research
Each year, approximately 900,000 patients in the US are affected by a pulmonary embolism (PE), a blood clot causing a blockage in one or more pulmonary arteries in the lungs. PE is a leading cause of in-hospital death in the US, and acute PE – a sudden blockage...
by Truveta Research | Mar 6, 2024 | Research, Research Insights
Disparities in time to treatment and treatment outcomes exist for people with severe aortic stenosis receiving TAVR and SAVR procedures. We studied the rate of people who receive TAVR, SAVR, aortic valve repair, and aortic balloon valvuloplasty procedures and time to...
